PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS CONTAINING SULFATED VINYL POLYMERS FOR TREATING RETROVIRUS CONTAMINATIONS

Sulphated vinyl polymers such as sulphated polyvinylalcohol, sulphated copolymers of (meth)acrylic acid and vinylalcohol, and pharmaceutically acceptable salts thereof, have an antiviral effect against human immunodeficiency virus and may therefore be used as a therapeutic agent for treating retrovi...

Full description

Saved in:
Bibliographic Details
Main Authors NAGY,MIKLOS,HU, LUW,MIKLOS,HU, BABA,MASANORI,BE, GYOERGYI,SANDORNE,HU, GOEROEG,SANDOR,HU, DE CLERCQ,ERIK DESIRE ALICE,BE
Format Patent
LanguageEnglish
Published 28.12.1990
Edition5
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Sulphated vinyl polymers such as sulphated polyvinylalcohol, sulphated copolymers of (meth)acrylic acid and vinylalcohol, and pharmaceutically acceptable salts thereof, have an antiviral effect against human immunodeficiency virus and may therefore be used as a therapeutic agent for treating retrovirus infections like AIDS and AIDS-related diseases. Their antiviral activity is apparently based on inhibition of virus adsorption; their inhibitory effect on giant cell formation is stronger than that of dextran sulphate.
Bibliography:Application Number: HU19900000886